Kopin Stock Price, News & Analysis

Kopin (NASDAQ: KOPN) reported financial results for Q2 2024, showing significant growth in defense product revenues. Key highlights include:

- Q2 2024 product revenues increased 84% year-over-year
- Defense product revenues surged 106%, offset by a 30% decrease in Industrial product revenues
- Five new customers placed development orders, potentially leading to multi-million dollar annual production revenues
- Gross margins improved due to operational excellence and reduced rework costs
- Net loss narrowed to ($5.9) million, or ($0.05) per share, compared to ($8.2) million, or ($0.07) per share in Q2 2023

The company secured new contracts, including a development award for the U.S. Army's Next Generation-Short Range Interceptor system, which could generate tens of millions in peak annual revenue by 2027.

Kopin (NASDAQ: KOPN), a leading provider of optical solutions and microdisplays for defense, enterprise, consumer, and medical products, has scheduled its second quarter 2024 earnings call for Thursday, August 8, 2024, at 8:30 AM Eastern Time. The company will discuss financial results for the quarter ended June 30, 2024, which will be released in a press release before the call.

Investors can join the call via phone or webcast. The U.S. dial-in number is 888-349-0106, while the international number is 412-902-0131. A webcast link will be available on Kopin's investor relations website. A replay of the call will be accessible through August 15, 2024, using toll-free (877-344-7529) or international (412-317-0088) numbers with the passcode 10191338.

Kopin (NASDAQ: KOPN) has secured a $1.5 million follow-on contract to supply a near eye, thermal imaging vision system for firefighter masks. The system includes a miniaturized AMLCD and optics integrated into the mask's facepiece, connected to a small thermal camera mounted on the side. This hands-free solution allows firefighters to view clear, real-time thermal imagery in their line of sight, unaffected by smoke or other environmental conditions.

The system aims to enhance firefighters' effectiveness during search and rescue missions by freeing up both hands and providing greater situational awareness. Deliveries for this contract are planned throughout the 2025 calendar year.

Kopin (NASDAQ: KOPN) has reached a significant milestone in developing its NeuralDisplay™ platform software, advancing to the Alpha testing stage. This innovative technology aims to revolutionize OLEDoS and MicroLED microdisplays for spatial computing applications. NeuralDisplay™ integrates RGB pixels, image-sensing pixels, and advanced algorithms to achieve high-fidelity eye tracking and neurological response analysis while maintaining real-time display performance.

Key features include:

• Potential elimination of dedicated eye-tracking cameras
• Dynamic brightness, contrast, and gaze controls
• Eye fatigue monitoring
• Rapid response to neurological stimuli

A demonstration video showcases the software's capability to control a spaceship using eye movements, highlighting its potential across various industries.

Kopin (NASDAQ: KOPN) has achieved a significant milestone in the production qualification of its high-performance Organic Light Emitting Diode on Silicon (OLEDoS) display for the F-35 Lightning II Helmet Mounted Display System (HMDS). This achievement marks the final step before customer qualification and flight testing.

Kopin is the sole-source supplier of high-brightness AMLCD displays for F-35 helmets under a multi-year procurement agreement. The company's next-generation OLEDoS technology is set to replace the current display technology in the coming years. Collins Aerospace, an RTX business, will fund Kopin's purchase of production test equipment to scale OLEDoS to full mass-production.

This development positions Kopin to continue as the exclusive provider of production displays for the F-35 HMDS through two generations of display technologies, supporting the largest procurement program in the Department of Defense.

Kopin (NASDAQ: KOPN) has partnered with Wilcox Industries to develop the FUSION CLAW™ head borne information system. This cutting-edge modular technology platform integrates night vision, communications, IFF, AI-informed power prioritization, multi-spectral forward illumination, mission recording, and Day/Night Heads-Up Display (HUD) into a lightweight package.

Kopin's role involves developing look-through mixed reality accessories, enhancing warfighter situational awareness with advanced Day and Night HUDs. The system works with legacy fielded systems and addresses the growing demand for sophisticated Visual Augmentation Solutions (VAS). With over 70,000 systems fielded and 100 commercial licensees integrating with ATAK, this partnership aims to revolutionize battlefield technology and create significant revenue potential.

Kopin announced its Vision System Demo Days event in New York City from July 16-18, 2024. The event will showcase the company's latest wearable vision and software solutions for defense, medical, and consumer applications.

Attendees will experience groundbreaking technologies, including a full-color daytime Heads-Up Display (HUD) for helmets, a night vision goggle overlay HUD, a medical wearable surgical monitor, and NeuralDisplay™ eye tracking software. The event will feature demonstrations and discussions led by Kopin's engineering experts, with presentations from CEO Michael Murray and the leadership team.

The event highlights Kopin's commitment to innovation in wearable and spatial computing, providing hands-on experience with its advanced ergonomics, human-centric design, and data visualization capabilities.

Kopin (NASDAQ: KOPN) has expanded its medical technology offerings by introducing high-resolution, fast Spatial Light Modulators (SLMs) for fluorescence super-resolution microscopes used in biomedical research. These SLMs can produce highly detailed images, enhancing research capabilities at leading institutions.

The EPFL in Lausanne, Switzerland, has developed an open-source add-on, openSIM, which integrates Kopin's SLMs into existing microscopes, transforming them into Structured Illumination super-resolution Microscopes (SIM). This allows researchers to upgrade equipment cost-effectively.

Additionally, the European Molecular Biology Lab (EMBL) in Heidelberg, Germany, has utilized Kopin's fast-switching binary Ferroelectric LCOS (FLCOS) technology to develop a state-of-the-art 3D MINFLUX optical system with nanometer-scale resolution. This open-source approach offers cost-effective solutions and advances biomedical research capabilities.

For more details, visit www.kopin.com.

Kopin (NASDAQ: KOPN) has been awarded a contract to create a high-resolution eyepiece assembly for the U.S. Army's Next Generation-Short Range Interceptor (NG-SRI) system. This eyepiece will be used in the Commanders Launch Assembly (CLA), part of the Army's efforts to replace outdated Stinger missiles with more advanced technology. The NG-SRI aims to enhance short-range air defense by achieving faster speeds, overcoming enemy jamming, and targeting drones more accurately. Kopin's Senior VP, Bill Maffucci, highlighted the potential financial impact, estimating revenue of $5 to $10 million annually once production starts.